Canada markets closed

Candel Therapeutics, Inc. (CADL)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
12.27+0.29 (+2.42%)
At close: 04:00PM EDT
12.28 +0.01 (+0.08%)
After hours: 07:05PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
2019-12-31
Total Revenue
0
0
125
125
125
-
Operating Expenses
Research Development
23,139
24,506
20,787
15,178
8,754
-
Selling General and Administrative
13,521
13,885
14,060
10,673
5,181
-
Total Operating Expenses
36,672
38,391
34,799
24,775
13,311
-
Operating Income or Loss
-36,672
-38,391
-34,674
-24,650
-13,186
-
Interest Expense
2,632
2,595
1,708
53
-
-
Total Other Income/Expenses Net
249
966
16,370
-11,421
-4,605
-
Income Before Tax
-37,365
-37,939
-18,794
-36,124
-17,680
-
Income from Continuing Operations
-37,365
-37,939
-18,794
-36,124
-17,680
-
Net Income
-37,365
-37,939
-18,794
-36,124
-17,680
-
Net Income available to common shareholders
-37,365
-37,939
-18,794
-36,124
-17,680
-
Basic EPS
-1.10
-
-0.65
-1.91
-0.94
-0.44
Diluted EPS
-1.10
-
-0.65
-1.91
-0.94
-0.44
Basic Average Shares
28,915
-
28,823
18,873
18,714
18,682
Diluted Average Shares
28,915
-
28,823
18,873
18,714
18,682